For decades, treatment success in dermatology was defined as keeping symptoms tolerable. Modern therapies have raised the bar: for many patients, clear or almost-clear skin — true remission — is now an achievable goal.
This article makes the case that coverage policy has not caught up with clinical reality. When utilization management keeps patients cycling through older, less effective treatments, the cost is measured in flares, missed work and diminished mental health.
This is sample article copy — replace it with the full text or a summary and link from the site admin.
